Dysregulation of the PPARα/PGC-1α axis is associated with impaired fatty acid oxidation and increased lipid accumulation, as observed in MASLD [26]. This evidence concerns the gene PPARGC1A and metabolic dysfunction-associated steatotic liver disease.